Prudential Financial Inc Reata Pharmaceuticals Inc Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $174,917 - $232,656	2,208 New	2,208 $225,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $60,567 - $262,420	-2,365 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $20,500 - $29,319	205 Added 9.49%	2,365 $238,000
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $964,912 - $1.87 Million	-12,328 Reduced 85.09%	2,160 $306,000
Q1 2020 May 12, 2020	BUY	$124.16 - $247.74 $1.56 Million - $3.12 Million	12,587 Added 662.13%	14,488 $2.09 Million
Q4 2019 Feb 11, 2020	SELL	$74.57 - $217.92 $21,252 - $62,107	-285 Reduced 13.04%	1,901 $388,000
Q2 2019 Aug 08, 2019	BUY	$77.72 - $94.35 $169,895 - $206,249	2,186 New	2,186 $0

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.